Cargando…

Recent advances in the management of anaplastic thyroid cancer

Anaplastic thyroid cancer (ATC) is undoubtedly the thyroid cancer histotype with the poorest prognosis. The conventional treatment includes surgery, radiotherapy, and conventional chemotherapy. Surgery should be as complete as possible, securing the airway and ensuring access for nutritional support...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Leo, Simone, Trevisan, Matteo, Fugazzola, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684758/ https://www.ncbi.nlm.nih.gov/pubmed/33292371 http://dx.doi.org/10.1186/s13044-020-00091-w

Ejemplares similares

Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
por: Colombo, Carla, et al.
Publicado: (2023)

Recent advances and emerging therapies in anaplastic thyroid carcinoma
por: Cabanillas, Maria E., et al.
Publicado: (2018)

Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
por: Colombo, Carla, et al.
Publicado: (2021)

Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
por: Yuan, Jiaqian, et al.
Publicado: (2022)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
por: Lee, Jieun, et al.
Publicado: (2013)

Daily Management of Patients on Multikinase Inhibitors’ Treatment
por: Colombo, Carla, et al.
Publicado: (2022)

Persistent Thyroid Carcinoma and Pregnancy: Outcomes in an Italian Series and Review of the Literature
por: Colombo, Carla, et al.
Publicado: (2022)

Post-Surgical Ablative or Adjuvant Radioiodine Therapy Has No Impact on Outcome in 1–4 cm Differentiated Thyroid Cancers without Extrathyroidal Extension
por: De Leo, Simone, et al.
Publicado: (2021)

The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association
por: Fugazzola, Laura, et al.
Publicado: (2013)

Therapeutic advances in anaplastic thyroid cancer: a current perspective
por: Saini, Shikha, et al.
Publicado: (2018)

Recent advances in managing differentiated thyroid cancer
por: Lamartina, Livia, et al.
Publicado: (2018)

Recent Advances in the Surgical Management of Thyroid Cancer
por: Scheller, Boris, et al.
Publicado: (2023)

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2020)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer
por: Kasemsiri, Pornthep, et al.
Publicado: (2021)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Anticancer effects of natural phytochemicals in anaplastic thyroid cancer
por: Li, Yitian, et al.
Publicado: (2022)

Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
por: Trevisan, Matteo, et al.
Publicado: (2022)

The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015)

A New Aurora in Anaplastic Thyroid Cancer Therapy
por: Baldini, Enke, et al.
Publicado: (2014)

MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2014)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Anaplastic Cancer of the Thyroid: The Viper in the Pit
por: Seshadri, Krishna G.
Publicado: (2019)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance
por: Fugazzola, Laura, et al.
Publicado: (2020)

Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021)

Molecular-targeted therapy for advanced anaplastic thyroid cancer combined with nutritional support
por: Maegawa, Yuka, et al.
Publicado: (2019)

Anaplastic thyroid cancer: How far can we go?
por: Amaral, Mariana, et al.
Publicado: (2020)

Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
por: Nagaiah, Govardhanan, et al.
Publicado: (2011)

Recent Advances in Molecular Diagnosis of Thyroid Cancer
por: Legakis, Ioannis, et al.
Publicado: (2011)

Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
por: Marvaso, Giulia, et al.
Publicado: (2022)

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer
por: Denaro, Nerina, et al.
Publicado: (2013)

Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review)
por: Alhejaily, Abdul-Mohsen G., et al.
Publicado: (2023)

Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy
por: Wang, Jingjing, et al.
Publicado: (2023)

Imaging of the thyroid: Recent advances
por: Chaudhary, Vikas, et al.
Publicado: (2012)

Roles of Non-Coding RNAs on Anaplastic Thyroid Carcinomas
por: Das, Plabon Kumar, et al.
Publicado: (2020)

New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)—Positive Cancer
por: Villa, Matteo, et al.
Publicado: (2021)

Anaplastic thyroid cancer: multimodal treatment results
por: Aslan, Zaki Antonio Taissoun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ofls8lhk5bua3gl7h8qh4njjq5